Orexo AB (publ) (LON:0H19)
38.25
-1.80 (-4.49%)
At close: Oct 15, 2025
Orexo AB Market Cap
Orexo AB has a market cap or net worth of 103.70 million as of October 16, 2025. Its market cap has increased by 187.70% in one year.
Market Cap
103.70M
Enterprise Value
133.29M
Revenue
43.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.25
Market Cap Chart
Since November 9, 2005, Orexo AB's market cap has increased from 60.62M to 103.70M, an increase of 71.07%. That is a compound annual growth rate of 2.73%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 16, 2025 | 103.70M | 137.35% |
Dec 30, 2024 | 43.69M | 5.47% |
Dec 29, 2023 | 41.42M | -19.73% |
Dec 30, 2022 | 51.61M | -46.80% |
Dec 30, 2021 | 97.01M | -36.97% |
Dec 30, 2020 | 153.91M | -13.55% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 196.07B |
HSBC Holdings | 170.14B |
Shell | 156.20B |
Unilever | 112.21B |
Rolls-Royce Holdings | 93.64B |
Rio Tinto Group | 87.87B |
British American Tobacco p.l.c. | 82.74B |
GSK plc | 65.48B |